戻る Agenda
ON DEMAND - Setting a Strategic Foundation for Mutually Beneficial Collaborations Between Industry and Patient Organizations
Session Chair(s)
Ellen Coleman, MPH, MS
President and Chief Executive Officer
VOZ Advisors, United States
This forum will share recommendations and present examples for how companies can strategically and compliantly identify and engage priority patient organizations and patients to collaborate on shared goals across the drug development continuum.
Learning Objective : Discuss best practices for evaluating and identifying priority organizations; Identify appropriate timing for conducting environmental assessments and how their insights can be used to enhance knowledge for cross-functional teams; Define the lifecycle of a patient organization, common challenges they experience and how industry can help organizations build capacity
Speaker(s)
How the Right Relationships Support Business Objectives
David G Dubinski, MBA
Blueprint Medicine, United States
Head of Global Patient Affairs
Why All Patient Stories Are Not Equal?
Mary McGowan
The Myositis Association, United States
Executive Director
A Comprehensive Approach to Patient Centricity: Case Study and Data Review of a Joint Pharma, Advocacy, and Partner Effort
Brianne Peters, MBA, MSN, RN
Science 37, United States
Sr. Director of Nursing Solutions
Industry Update
Jennifer Brandl
Kezar Life Sciences, United States
Senior Clinical Trial Manager